Recurrent hyperlipidemic acute pancreatitis： Etiology and prevention and treatment strategies
Journal Title: Journal of Clinical Hepatology - Year 2024, Vol 40, Issue 10
Abstract
The incidence rate of hyperlipidemic acute pancreatitis （HLAP） is gradually increasing， with the features of young age， severe conditions， frequent recurrence， and poor prognosis， and recurrent HLAP has become a difficult issue that needs to be solved urgently in clinical practice. This article summarizes the risk factors for HLAP recurrence and corresponding prevention and treatment strategies. The risk factors for HLAP recurrence include dyslipidemia， abnormal glucose metabolism， obesity， smoking， and drinking. In addition to the early treatment in the acute stage， HLAP requires long-term management， including effective control of blood glucose and lipids， diet regulation， and cigarette and alcohol withdrawal. As for patients with unexplained recurrent HLAP， genetic testing and gene therapy may provide novel diagnosis and treatment strategies.
Authors and Affiliations
Lina QI, Ping CHEN
Keywords
Related Articles
- EP ID EP751068
- DOI 10.12449/JCH241030
- Views 24
- Downloads 0
Effect of ganoderic acid A on a mouse model of concanavalin A-induced acute immune liver injury and its mechanism
[Objective] To investigate the therapeutic effect of ganoderic acid A （GA-A） on a mouse model of concanavalin A （ConA）-induced autoimmune hepatitis （AIH）. [Methods] A total of 35 mice were randomly divided into con...
The role of CD8+ T cells in nonalcoholic steatohepatitis
Nonalcoholic steatohepatitis （NASH） is a liver disease closely associated with metabolic syndrome， and its pathogenesis includes insulin resistance， lipid metabolism disorders， and inflammatory response. This articl...
Efficacy and safety of camrelizumab monoclonal antibody combined with molecular-targeted therapy in elderly patients with advanced hepatocellular carcinoma
[Objective] To investigate the efficacy and safety of camrelizumab monoclonal antibody combined with molecular-targeted therapy in elderly patients with unresectable or advanced hepatocellular carcinoma （HCC）. [Methods...
Effectiveness of fibrosis-4 versus aspartate aminotransferase-to-platelet ratio index in evaluating liver fibrosis degree in patients with chronic HBV infection
[Objective] To investigate the performance of fibrosis-4 （FIB-4） versus aspartate aminotransferase-to-platelet ratio index （APRI） in predicting advanced liver fibrosis and disease progression in patients with chronic...
Effect of Qizhu prescription on a mouse model of non-alcoholic fatty liver disease incluced by high-fat， high-fructose， and high-cholesterol diet and its mechanism
[Objective] To investigate the therapeutic effect and mechanism of action of Qizhu prescription in mice with non-alcoholic fatty liver disease （NAFLD）. [Methods] A total of 60 male C57BL/6J mice were randomly divided i...